Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Cervical Cancer Awareness Month: 2022 Immunotherapy Research Updates

    New research, new treatments, and how we’re working toward a future immune to cervical cancer

    January 12, 2022| CRI Staff
  • COVID-19 and Cancer Vaccines with Immunotherapy Pioneers Ugur Sahin and Özlem Türeci

    Ugur Sahin and Ozlem Tureci, two of this year’s CRI Coley Award recipients, are pioneers of the…

    December 21, 2021| Arthur N. Brodsky, PhD
  • Dr. Dmitriy Zamarin Answers Questions About Ovarian Cancer and Immunotherapy after the 2021 CRI Virtual Immunotherapy Patient Summit

    Dr. Dmitriy Zamarin, of Memorial Sloan Kettering Cancer Center, answers questions about immunotherapy clinical trials from the…

    December 14, 2021| CRI Staff
  • Dr. Ana Aparicio Answers Questions About Prostate Cancer and Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit

    Dr. Ana Aparicio, of The University of Texas MD Anderson Cancer Center, answers questions about prostate cancer…

    December 13, 2021| CRI Staff
  • Dr. Nabil F. Saba Answers Questions About Head and Neck Cancer and Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit

    Dr. Nabil F. Saba, of Winship Cancer Institute at Emory University, answers questions about immunotherapy for head…

    December 10, 2021| CRI Staff
  • Dr. Van Morris Answers Questions About Colorectal Cancer and Immunotherapy at the 2021 CRI Virtual Immunotherapy Patient Summit

    Dr. Van Morris, of MD Anderson Cancer Center, answers questions about immunotherapy clinical trials from the 2021…

    December 9, 2021| CRI Staff
  • Dr. Hearn Jay Cho Answers Questions About Blood Cancer And Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit

    Dr. Hearn Jay Cho, of Mount Sinai Tisch Cancer Institute, answers questions about blood cancer and immunotherapy…

    December 8, 2021| CRI Staff
  • Dr. Kunle Odunsi Answers Questions About Immunotherapy Clinical Trials After the 2021 CRI Virtual Immunotherapy Patient Summit

    Dr. Kunle Odunsi, of the University of Chicago Medicine Comprehensive Cancer Center, answers questions about immunotherapy clinical…

    December 7, 2021| CRI Staff
  • Dr. Ellen Puré Answers Questions About The Basics of Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit

    Dr. Ellen Puré, of the University of Pennsylvania, answers questions about the basics of immunotherapy after the…

    December 6, 2021| CRI Staff
Previous Page
1 … 27 28 29 30 31 … 98
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal